Risk and Benefits of Electronic Cigarettes to Older Smokers at High Risk for Lung Cancer
Status:
Not yet recruiting
Trial end date:
2025-04-30
Target enrollment:
Participant gender:
Summary
This clinical trial investigates the effects of switching from smoking regular cigarettes to
electronic cigarettes (e-cigarettes) among older adult smokers at high risk for lung cancer.
E-cigarettes use heated vapor to deliver nicotine. Information gained from this trial may
help inform regulators of the potential risks and benefits of switching smokers at high risk
for lung cancer to electronic cigarettes. This research also may help inform the Food and
Drug Administration (FDA) how best to regulate e-cigarettes with the goal of improving public
health.